☆ 4.7 Meeting Abstract

A phase lb trial with MK-8628/OTX015, a small molecule inhibitor of bromodomain (BRD) and extra-terminal (BET) proteins, in patients with selected advanced solid tumors

EUROPEAN JOURNAL OF CANCER (2016)

Get Full Text
Add to Collection

Journal

EUROPEAN JOURNAL OF CANCER
Volume 69, Issue -, Pages S2-S3

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S0959-8049(16)32609-0

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.